skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Human Papillomavirus Vaccine V503 (Code C71520)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Human Papillomavirus Vaccine V503

Definition: A vaccine consisting of noninfectious, recombinant virus-like particles (VLP) containing the major viral capsid protein L1 of nine strains of human papillomavirus (HPV), with potential immunoprotective activity. Vaccination with HPV V503 may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against cells positive for any of these nine strains of HPV, thereby preventing cervical infection upon exposure to certain HPV subtypes.

Display Name: Human Papillomavirus Vaccine V503

Label: Human Papillomavirus Vaccine V503

NCI Thesaurus Code: C71520 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL376226  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Human Papillomavirus Vaccine V503

External Source Codes: 
PDQ Closed Trial Search ID 574540
PDQ Open Trial Search ID 574540 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C71520
Contributing_Source CTRP
Legacy_Concept_Name Human_Papillomavirus_V503_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom